Lateral Flow Assay to Detect Carbonic Anhydrase IX in Seromas of Breast Implant-Associated Anaplastic Large Cell Lymphoma
We conclude that CA9 is a sensitive biomarker for detection and screening of patients for BIA-ALCL in patients who present with seromas of unknown etiology. The CA9 LFA can potentially replace ELISA, flow cytometry and other tests requiring specialized equipment, highly trained personnel, larger amounts of fluid and delay in diagnosis of BIA-ALCL.
Authors
- Richard Willson
- Marshall E. Kadin
- Honghua Hu (ORCID: https://orcid.org/0000-0002-3749-4089)
- Katerina Kourentzi (ORCID: https://orcid.org/0000-0001-5891-6415)
- Anand K. Deva (ORCID: https://orcid.org/0000-0002-0314-7177)
- Peng Xu (ORCID: https://orcid.org/0000-0002-2673-7161)
- Chris A. Campbell (ORCID: https://orcid.org/0000-0003-3308-5517)
Institutions
- University of Virginia Health System (US)
- University of Houston (US)
- University of Virginia (US)
- Macquarie University (AU)
Publication Details
- Journal
- Cancers
- Published
- 2025-07-21
- DOI
- https://doi.org/10.3390/cancers17142405
- Citations
- 1
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 2.01